Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/34832
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKoca, Süleyman Serdar-
dc.contributor.authorÖz, Burak-
dc.contributor.authorKarataş, Ahmet-
dc.contributor.authorCan, Gercek-
dc.contributor.authorŞenel, Soner-
dc.contributor.authorYazıcı, Ayten-
dc.contributor.authorİnanç, Nevsun-
dc.contributor.authorCefle, Ayşe-
dc.contributor.authorErtürk, Zeynep-
dc.contributor.authorAkar, Servet-
dc.contributor.authorGöker, Berna-
dc.contributor.authorBirlik, Merih-
dc.contributor.authorÖnen, Fatoş-
dc.date.accessioned2023-11-10T07:06:17Z-
dc.date.available2023-11-10T07:06:17Z-
dc.date.issued2018-06-
dc.identifier.citationKoca, S. S. vd. (2018). ''Concomitant use of corticosteroids at the baseline does not affect the drug survival of abatacept in rheumatoid arthritis''. Annals of the Rheumatic Diseases, 77(Supplement 2), 597-597.en_US
dc.identifier.issn0003-4967-
dc.identifier.issn1468-2060-
dc.identifier.urihttps://doi.org/10.1136/annrheumdis-2018-eular.5819-
dc.identifier.urihttps://ard.bmj.com/content/77/Suppl_2/597.1-
dc.identifier.urihttp://hdl.handle.net/11452/34832-
dc.descriptionBu çalışma, 13-16, Haziran 2018 tarihlerinde Amsterdam[Hollanda]’da düzenlenen Congress of the European-League-Against-Rheumatism (EULAR) Kongresi‘nde bildiri olarak sunulmuştur.tr_TR
dc.description.sponsorshipEuropean League Against Rheumatismen_US
dc.language.isoenen_US
dc.publisherBMJen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAtıf Gayri Ticari Türetilemez 4.0 Uluslararasıtr_TR
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectRheumatologyen_US
dc.titleConcomitant use of corticosteroids at the baseline does not affect the drug survival of abatacept in rheumatoid arthritisen_US
dc.typeMeeting Abstracten_US
dc.identifier.wos000444351001568tr_TR
dc.relation.publicationcategoryKonferans Öğesi - Uluslararasıtr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Dahiliye Anabilim Dalı/Romatoloji Bilim Dalı.tr_TR
dc.identifier.startpage597tr_TR
dc.identifier.endpage597tr_TR
dc.identifier.volume77tr_TR
dc.identifier.issueSupplement 2en_US
dc.relation.journalAnnals of the Rheumatic Diseasesen_US
dc.contributor.buuauthorDalkılıç, Ediz-
dc.contributor.buuauthorPehlivan, Yavuz-
dc.contributor.buuauthorYağız, Burcu-
dc.contributor.researcheridAAG-8227-2021tr_TR
dc.relation.collaborationYurt içitr_TR
dc.subject.wosRheumatologyen_US
dc.indexed.wosSCIEen_US
dc.indexed.wosCPCISen_US
dc.wos.quartileQ1en_US
Appears in Collections:Web of Science

Files in This Item:
File Description SizeFormat 
Dalkılıç_vd_2018.pdf743.46 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons